Exelixis, Inc. (EXEL)
50.13
-0.97
(-1.90%)
USD |
NASDAQ |
May 15, 16:00
50.14
+0.02
(+0.03%)
After-Hours: 20:00
Exelixis Market Cap : 12.60B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 275.09B |
| Madrigal Pharmaceuticals, Inc. | 12.07B |
| Krystal Biotech, Inc. | 9.029B |
| Arcus Biosciences, Inc. | 2.991B |
| Immunome, Inc. | 2.365B |
Market Cap Related Metrics
| PE Ratio | 16.61 |
| PS Ratio | 5.838 |
| PEG Ratio | 0.4505 |
| Price to Book Value | 6.509 |
| Price to Free Cash Flow | 15.11 |
| Price | 50.13 |
| Earnings Yield | 6.02% |
| PEGY Ratio | 0.4505 |
| Operating PE Ratio | 14.49 |
| Normalized PE Ratio | 16.34 |